Insulet (PODD) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts PODD Hot Sheet
Price: $142.28 -3.53%
Revenue Growth %: +18.1%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of $0.02, in-line with the analyst estimate of $0.02. Revenue for the quarter came in at $177.1 million versus the consensus estimate of $163.66 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- JPMorgan Downgrades AVI Limited (AVI:SJ) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
